Case study: Jiangsu Weilon's 12-month playbook into Indonesia's top-3 pharmas
From zero to three tier-1 pharma contracts in 12 months — Jiangsu Weilon's Indonesia playbook: platform inquiries + BPOM concierge + on-site Jakarta engineer.
Jiangsu Weilon Filling Machinery ('Weilon') is a 16-year-old Changzhou-based pharma equipment maker, specialized in high-speed filling and capping. In May 2025, they decided to actively pursue overseas markets — starting with Indonesia. Twelve months later, they had contracts with Kalbe, Kimia Farma, and Phapros totaling USD 4.8M.
Timeline
- 2025-05 Completed the Export Readiness Assessment, scored 78, entered Indonesia priority shortlist.
- 2025-06 Partnered with Jakarta agent PT Maju Bersama (NIB-licensed), filed BPOM application.
- 2025-08 First platform inquiry — Saka Farma (Kalbe subsidiary), high-speed filling line.
- 2025-10 BPOM certificate issued in 4.5 months.
- 2025-11 Dispatched a resident engineer to Jakarta service center.
- 2025-12 Kalbe first contract: 1 filling line, USD 1.8M.
- 2026-02 Kimia Farma follow-up: 2 filling lines, USD 2.3M.
- 2026-04 Phapros referral via Indonesian account manager: 1 line, USD 700K.
Three decisions that mattered
Weilon's GM kept returning to three points in the post-mortem: 'People before orders' — they sent the engineer the moment BPOM landed, not after the first contract. 'Indonesian before English' — first version of key docs went Indonesian, then English; counterintuitive but matches local decision rhythm. 'Slow before fast' — first deal took 4 months of grinding; the next two combined took 3.
Three prerequisites to replicate this playbook
(1) One engineer willing to relocate to ASEAN for 6+ months; (2) platform inquiry conversion ≥ 30% (real product-market fit in Indonesia); (3) USD 300K starting cash (BPOM + agent + dispatch).